» Articles » PMID: 15893521

Agonist-induced Up-regulation of Human Somatostatin Receptor Type 1 is Regulated by Beta-arrestin-1 and Requires an Essential Serine Residue in the Receptor C-tail

Overview
Specialties Biochemistry
Biophysics
Date 2005 May 17
PMID 15893521
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that the human somatostatin receptor type 1 (hSSTR1) does not undergo agonist-induced internalization, but is instead up-regulated at the membrane upon prolonged somatostatin (SST) exposure. The deletion of the carboxyterminal C-tail of the receptor completely abolishes up-regulation. To identify molecular signals that mediate hSSTR1 up-regulation, we created mutant receptors with progressive C-tail deletions. Up-regulation was found to be absent in mutants lacking residues Lys359-Ser360-Arg361. Moreover, point mutation of Ser360 to Ala completely abolished up-regulation. The coexpression of wild type hSSTR1 with V53D, a dominant negative mutant of beta-arrestin-1, completely blocked hSSTR1 up-regulation. Further analysis demonstrated that calcium-calmodulin (CaM) dependent kinases were essential for the SST-induced up-regulation response. Like wild type receptors, all mutants failed to internalize after agonist exposure and were able to inhibit forskolin-stimulated cAMP accumulation. Taking these data together, we suggest that SST-induced hSSTR1 up-regulation is critically dependent upon a specific Lys-Ser-Arg sequence in the C-tail of the receptor, with Ser360 being essential. Up-regulation also requires the participation of CaM protein kinases and interactions with beta-arrestins. In contrast, coupling to adenyl cyclase (AC) and internalization occur independently of molecular signals in the receptor's C-tail.

Citing Articles

Understanding the influence of lipid bilayers and ligand molecules in determining the conformational dynamics of somatostatin receptor 2.

Nagarajan S, Babu S, Kulkarni S, Vadivelu A, Devaraju P, Sohn H Sci Rep. 2021; 11(1):7677.

PMID: 33828200 PMC: 8027056. DOI: 10.1038/s41598-021-87422-5.


International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Gunther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp H Pharmacol Rev. 2018; 70(4):763-835.

PMID: 30232095 PMC: 6148080. DOI: 10.1124/pr.117.015388.


GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation.

Madsen L, Knauf J, Gotfredsen C, Pilling A, Sjogren I, Andersen S Endocrinology. 2012; 153(3):1538-47.

PMID: 22234463 PMC: 3281535. DOI: 10.1210/en.2011-1864.


Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.

Moncayo R EJNMMI Res. 2012; 1(1):9.

PMID: 22214590 PMC: 3251005. DOI: 10.1186/2191-219X-1-9.


Glutamate differently modulates metabotropic glutamate receptors in neuronal and glial cells.

Castillo C, Leon D, Ballesteros-Yanez I, Iglesias I, Martin M, Albasanz J Neurochem Res. 2010; 35(7):1050-63.

PMID: 20309728 DOI: 10.1007/s11064-010-0154-y.